StockData
Guardant Health, Inc. logo

Guardant Health, Inc. (GH) stock

GHNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$143.28−0.75 (-0.52%)

Close on Nov 17, 2026Market cap $19.23BP/E –Yield –

Guardant Health operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Guardant Health's operating income for the twelve months ending Jun 30, 2026 was -$470.26M. For fiscal 2025 it was -$437.25M. The highest annual figure on record is -$43.85M in fiscal 2016.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$437.25M–
FY2024Dec 31, 2024-$443.59M–
FY2023Dec 31, 2023-$564.73M–
FY2022Dec 31, 2022-$544.38M–
FY2021Dec 31, 2021-$411.00M–
FY2020Dec 31, 2020-$254.95M–
FY2019Dec 31, 2019-$82.37M–
FY2018Dec 31, 2018-$92.94M–
FY2017Dec 31, 2017-$76.61M–
FY2016Dec 31, 2016-$43.85M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$129.12M–
Q1 FY2026Mar 31, 2026-$121.35M–
Q4 FY2025Dec 31, 2025-$120.81M–
Q3 FY2025Sep 30, 2025-$98.99M–
Q2 FY2025Jun 30, 2025-$106.41M–
Q1 FY2025Mar 31, 2025-$111.04M–
Q4 FY2024Dec 31, 2024-$125.97M–
Q3 FY2024Sep 30, 2024-$117.33M–
Q2 FY2024Jun 30, 2024-$100.62M–
Q1 FY2024Mar 31, 2024-$99.68M–
Q4 FY2023Dec 31, 2023-$197.51M–
Q3 FY2023Sep 30, 2023-$113.54M–
Q2 FY2023Jun 30, 2023-$119.62M–
Q1 FY2023Mar 31, 2023-$134.06M–
Q4 FY2022Dec 31, 2022-$146.12M–
Q3 FY2022Sep 30, 2022-$144.60M–
Q2 FY2022Jun 30, 2022-$130.32M–
Q1 FY2022Mar 31, 2022-$123.34M–
Q4 FY2021Dec 31, 2021-$98.21M–
Q3 FY2021Sep 30, 2021-$107.29M–
Q2 FY2021Jun 30, 2021-$97.64M–
Q1 FY2021Mar 31, 2021-$107.86M–
Q4 FY2020Dec 31, 2020-$91.17M–
Q3 FY2020Sep 30, 2020-$74.25M–
Q2 FY2020Jun 30, 2020-$54.62M–
Q1 FY2020Mar 31, 2020-$34.91M–
Q4 FY2019Dec 31, 2019-$25.96M–
Q3 FY2019Sep 30, 2019-$17.48M–
Q2 FY2019Jun 30, 2019-$15.27M–
Q1 FY2019Mar 31, 2019-$23.66M–
Q4 FY2018Dec 31, 2018-$27.39M–
Q3 FY2018Sep 30, 2018-$24.21M–
Q2 FY2018Jun 30, 2018-$22.70M–
Q1 FY2018Mar 31, 2018-$18.65M–
Q4 FY2017Dec 31, 2017-$15.62M–
Q3 FY2017Sep 30, 2017-$28.68M–

More Guardant Health figures

See a number that looks wrong?